*Haruka Hosoki1, Toru Asahi1,2, Chihiro Nozaki3 (1. Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan, 2. Research Organization for Nano & Life Innovation, Waseda University, Tokyo, Japan, 3. Global center for science and Engineering, Major in Bioscience, Waseda University, Tokyo, Japan)
セッション情報
[CINP2024] Poster Session
CINP2024 » Poster Session
Preclinical - Others (2)
2024年5月26日(日) 13:30 〜 14:30 CINP Poster Session Hall (Lobby Gallery)
*Sridhar Amalakanti1, Vijaya Chandra Reddy Avula2, Sachin Singh3 (1. Department of General Medicine, AIIMS Mangalagiri, Mangalagiri, India, 2. Department of Psychiatry, AIIMS Mangalagiri, Mangalagiri, India, 3. Epigenetics and Neuropsychiatry Lab, CCMB, Hyderabad, India)
*Tomohiro Tokutake1, Takashi Asano1, Naotaka Izuo1, Shin-Ichi Muramatsu2,3, Atsumi Nitta1 (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan, 2. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
*Hirohito Esaki1, Kanta Imai2, Keisuke Nishikawa2, Shoma Izumi1, Ayumu Inutsuka3, Kazuki Nagayasu4, Shuji Kaneko4, Naoya Nishitani1,2, Satoshi Deyama1,2, Katsuyuki Kaneda1,2 (1. Laboratory of Molecular Pharmacology, Institute of Medicine, Pharmaceutical, and Health Science, Kanazawa University, 2. Laboratory of Molecular Pharmacology, School of Pharmaceutical Science, Kanazawa University, 3. Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, 4. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Science, Kyoto University)
*Shoma Izumi1, Hirohito Esaki1, Naoya Nishitani1, Kazuki Nagayasu2, Shuji Kaneko2, Satoshi Deyama1, Katsuyuki Kaneda1 (1. Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., 2. Department of Molecular Pharmacology Graduate School of Pharmaceutical Sciences Kyoto University, Kyoto, Japan.)
*Hsiang-En Wu1, Shao-Ming Wang2,4, Chun-Yu Lin3,4, Fenf-Ju Weng2,4, Hsuan-Cheng Wu2,4, Leeodella Sands1, Tsung-Ping Su1 (1. Cellular Pathobiology Section, INRB, IRP, NIDA, NIH, 2. Graduate Institute of Biomedical Sciences, China Medical University, Taiwan, 3. School of Medicine, China Medical University, Taiwan, 4. 4Neuroscience and Brain Disease Center, China Medical University, Taiwan)
*Simon Couly1, Yuko Yasui1, Semnyonga Foncham1, Ioannis Grammatikakis2, Ashish Lal2, Lei Shi3, Tsung-Ping Su1 (1. Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute On Drug Abuse, NIH/DHHS, 333 Cassell Drive, Baltimore, MD, 21224, USA., 2. Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD, 20892, USA., 3. Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse, NIH/DHHS, 333 Cassell Drive, Baltimore, MD, 21224, USA.)
*Yuan Yao1, Ying Han1 (1. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing, China)
*Somrudee Saiyudthong1, Kosum Chansiri2, Brian Lee3, Phakkharawat Sittiprapaporn, Kanchanapa Sathirachawan1 (1. Department of Physiology, Faculty of Medicine, Srinakrarinwirot University, Bangkok, Thailand, 2. Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand, 3. Department of Internal Medicine, Faculty of Medicine, Srinakrarinwirot University, Bangkok, Thailand)
*Daisuke Nishizawa1, Ryozo Morino2, Rie Inoue1,3, Seii Ohka1, Shinya Kasai1, Junko Hasegawa1, Yuko Ebata1, Kyoko Nakayama1, Hiroyuki Sumikura3, Masakazu Hayashida1,3, Miyuki Yokota4,5, Kazutaka Ikeda1 (1. Department of Psychiatry and Behavioral Sciences (Addictive Substance Project), Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Division of Anesthesiology, Koujinkai Daiichi Hospital, Tokyo, Japan, 3. Department of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan, 4. Department of Anesthesiology, Cancer Institute Hospital, Tokyo, Japan, 5. Department of Anesthesiology, East Hokkaido Hospital, Kushiro, Japan)
*Konosuke Abe1, Kosuke Itoh1, Kosei Iwai1, Momoka Shimada1, Midori Soda1, Yasuhisa Oida1, Kiyoyuki Kitaichi1 (1. Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan.)